Rockwell Medical (RMTI) Tops Q1 EPS by 1c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.12 +0.37%
Revenue Growth %: +14.9%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +14.9%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.23 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $90-94 million, versus the consensus of $88.974 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
